Community Healthcare Trust earnings release, May 5, 2026

Community Healthcare Trust Inc (CHCT) · Form 8-K, Item 2.02 · Filed · SEC filing

News Release

Community Healthcare Trust Announces Results for the Three Months Ended March 31, 2026

FRANKLIN, Tenn., May 5, 2026 / PRNewswire / -- Community Healthcare Trust Incorporated (NYSE:

CHCT) (the "Company") today announced results for the three months ended March 31, 2026. The Company reported net income for the three months ended March 31, 2026 of approximately $2.5 million, or $0.07 per diluted common share. Funds from operations ("FFO") and adjusted funds from operations ("AFFO") for the three months ended March 31, 2026 totaled $0.49 and $0.56 per diluted common share, respectively.

Items Impacting Our Results include:

• During the first quarter of 2026, the Company acquired an inpatient rehabilitation facility in Florida upon completion of construction for a purchase price and cash consideration of approximately $28.5 million. The property was 100.0% leased to a tenant with a lease expiration in 2044 and an expected return of approximately 9.3%. The acquisition was funded with net proceeds from the Revolving Credit Facility and asset sales.

• During the first quarter of 2026, the Company disposed of one property and received net proceeds of approximately $5.2 million. The Company also received net proceeds of approximately $0.7 million for a property disposed of during the fourth quarter of 2025.

• During the first quarter of 2026, the geriatric behavioral hospital operator, a tenant in six of the Company's properties, paid $0.3 million in rent, an increase of $0.1 million from the fourth quarter of 2025. In July 2025, the tenant signed a Letter of Intent (LOI) for the sale of its business to a behavioral healthcare provider. The buyer is finalizing legal and business due diligence and has entered the drafting phase of the definitive purchase documents, including new leases on the six hospitals owned by the Company. While the transaction is progressing, the Company cannot provide assurance regarding the specific timing or the ultimate certainty of the closing.

• The Company has four properties under definitive purchase agreements, to be acquired after completion and occupancy, for an aggregate expected purchase price of approximately $99.0 million. The Company's expected returns on these investments are approximately 9.1% to 9.75%. The Company anticipates closing on these properties throughout 2026 and 2027; however, the Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close.

• During the first quarter of 2026, the Company did not issue any shares under its ATM program.

• On April 30, 2026, the Company’s Board of Directors declared a quarterly common stock dividend in the amount of $0.48 per share. The dividend is payable on May 22, 2026 to stockholders of record on May 11, 2026.

About Community Healthcare Trust Incorporated

Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. As of March 31, 2026, the Company had investments of approximately $1.2 billion in 198 real estate properties (including one property with sales-type leases). The properties are located in 36 states, totaling approximately 4.5 million square feet in the aggregate.

Additional information regarding the Company, including this quarter's operations, can be found at www.chct.reit. Please contact the Company at 615-771-3052 to request a printed copy of this information.¹

Financial statements

Income Statement

Three Months Ended — FINANCIAL HIGHLIGHTS (Unaudited and in thousands, except per share data)

Three Months Ended – 1Q 2026 – (Unaudited and in thousands, except per share data)Three Months Ended – 4Q 2025 – (Unaudited and in thousands, except per share data)Three Months Ended – 3Q 2025 – (Unaudited and in thousands, except per share data)Three Months Ended – 2Q 2025 – (Unaudited and in thousands, except per share data)Three Months Ended – 1Q 2025 – (Unaudited and in thousands, except per share data)
Revenues31,52430,94631,08629,08530,078
Net income (loss)2,54814,4281,640-12,5571,591
NOI25,15524,93225,15623,50023,983
EBITDAre20,05020,17320,5054,27418,886
Adjusted EBITDAre22,76122,77222,97020,06821,596
FFO13,39913,32913,5476,33612,668
AFFO15,35014,94315,09913,58514,739
Per Diluted Share: (1)(2)(3)(4)Net income (loss) attributable to common shareholders0.070.510.03-0.50.03
Per Diluted Share: (1)(2)(3)(4)FFO0.490.490.50.230.47
Per Diluted Share: (1)(2)(3)(4)AFFO0.560.550.560.50.55
Per Diluted Share: (1)(2)(3)(4)(1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share.(1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share.(1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share.(1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share.(1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share.(1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share.
Per Diluted Share: (1)(2)(3)(4)(2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share, FFO, and AFFO.(2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share, FFO, and AFFO.(2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share, FFO, and AFFO.(2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share, FFO, and AFFO.(2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share, FFO, and AFFO.(2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share, FFO, and AFFO.
Per Diluted Share: (1)(2)(3)(4)(3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business.(3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business.(3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business.(3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business.(3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business.(3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business.

Income Statement

Three Months Ended — CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited; Dollars and shares in thousands, except per share data)

Three Months Ended – 1Q 2026 – (Unaudited; Dollars and shares in thousands, except per share data)Three Months Ended – 4Q 2025 – (Unaudited; Dollars and shares in thousands, except per share data)Three Months Ended – 3Q 2025 – (Unaudited; Dollars and shares in thousands, except per share data)Three Months Ended – 2Q 2025 – (Unaudited; Dollars and shares in thousands, except per share data)Three Months Ended – 1Q 2025 – (Unaudited; Dollars and shares in thousands, except per share data)
REVENUESRental income31,26930,67930,81430,12829,730
REVENUESOther operating interest255267272-1,043348
REVENUES31,52430,94631,08629,08530,078
EXPENSESProperty operating6,3696,0145,9305,5856,095
EXPENSESGeneral and administrative (1)(2)5,1084,7784,65810,5595,100
EXPENSESDepreciation and amortization10,65710,81410,90210,87910,943
EXPENSES22,13421,60621,49027,02322,138
OTHER (EXPENSE) INCOME(Loss) gain, net of impairment, on the sale of real estate assets-4612,051-888640
OTHER (EXPENSE) INCOMEInterest expense-6,799-6,959-7,075-6,592-6,352
OTHER (EXPENSE) INCOMECredit loss reserve-8,672
OTHER (EXPENSE) INCOMEDeferred income tax expense-23
OTHER (EXPENSE) INCOMEInterest and other income, net319753
OTHER (EXPENSE) INCOME-6,8425,088-7,956-14,619-6,349
OTHER (EXPENSE) INCOMENET INCOME (LOSS)2,54814,4281,640-12,5571,591
OTHER (EXPENSE) INCOMENET INCOME (LOSS) PER DILUTED COMMON SHARE0.070.510.03-0.50.03
OTHER (EXPENSE) INCOMEWEIGHTED AVERAGE COMMON SHARES OUTSTANDING26,99126,95326,93426,80326,733
OTHER (EXPENSE) INCOMEDIVIDENDS DECLARED, PER COMMON SHARE, IN THE PERIOD0.47750.4750.47250.470.4675
Non-cash vs. Cash:Non-cash (stock-based compensation)53.154.452.954.353.1
Non-cash vs. Cash:Cash46.945.647.145.746.9
As a % of Revenue:Non-cash (stock-based compensation)8.68.488.79
As a % of Revenue:Cash7.677.17.37.9

Income Statement

Three Months Ended — ADJUSTED FUNDS FROM OPERATIONS (AFFO) (Unaudited; Dollars and shares in thousands, except per share data)

Three Months Ended – 1Q 2026 – (Unaudited; Dollars and shares in thousands, except per share data)Three Months Ended – 4Q 2025 – (Unaudited; Dollars and shares in thousands, except per share data)Three Months Ended – 3Q 2025 – (Unaudited; Dollars and shares in thousands, except per share data)Three Months Ended – 2Q 2025 – (Unaudited; Dollars and shares in thousands, except per share data)Three Months Ended – 1Q 2025 – (Unaudited; Dollars and shares in thousands, except per share data)
NET INCOME (LOSS)(1)(2)(3)(4)2,54814,4281,640-12,5571,591
Real estate depreciation and amortization10,80510,95211,01910,86111,077
Credit loss reserve8,672
Loss (gain), net of impairment, on the sale of real estate assets46-12,051888-640
FFO(1)(3)13,39913,32913,5476,33612,668
Straight-line rent-760-985-913-1,184-639
Stock-based compensation2,7112,5992,4652,5312,710
Accelerated amortization of stock-based compensation4,591
Severance and transition related expenses1,311
AFFO(2)(3)15,35014,94315,09913,58514,739
FFO PER COMMON SHARE0.490.490.50.230.47
AFFO PER COMMON SHARE0.560.550.560.50.55
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING27,57027,25927,19527,01127,007
________________(1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share.(1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share.
________________(2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share for net loss, FFO, and AFFO.(2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share for net loss, FFO, and AFFO.

Income Statement

Three Months Ended — NET OPERATING INCOME (NOI) (Unaudited; Dollars and shares in thousands, except per share data)

Three Months Ended – 1Q 2026 – (Unaudited; Dollars and shares in thousands, except per share data)Three Months Ended – 4Q 2025 – (Unaudited; Dollars and shares in thousands, except per share data)Three Months Ended – 3Q 2025 – (Unaudited; Dollars and shares in thousands, except per share data)Three Months Ended – 2Q 2025 – (Unaudited; Dollars and shares in thousands, except per share data)Three Months Ended – 1Q 2025 – (Unaudited; Dollars and shares in thousands, except per share data)
Net income (loss)(1)(2)2,54814,4281,640-12,5571,591
General and administrative(3)5,1084,7784,6584,6575,100
Accelerated amortization of deferred compensation4,591
Severance and transition-related compensation1,311
Depreciation and amortization10,65710,81410,90210,87910,943
Loss (gain), net of impairment, on the sales of real estate assets46-12,051888-640
Credit loss reserve8,672
Interest expense6,7996,9597,0756,5926,352
Deferred Income tax expense23
Interest and other income, net-3-19-7-5-3
NOI25,15524,93225,15623,50023,983
EBITDAreNet (loss) income (1)(2)2,54814,4281,640-12,5571,591
EBITDAreInterest expense6,7996,9597,0756,5926,352
EBITDAreDepreciation and amortization10,65710,81410,90210,87910,943
EBITDAreDeferred Income tax expense23
EBITDAreLoss (gain), net of impairment, on the sale of real estate assets46-12,051888-640
EBITDAre20,05020,17320,5054,27418,886
EBITDAreNon-cash stock-based compensation expense2,7112,5992,4652,5312,710
EBITDAreAccelerated amortization of stock-based compensation4,591
EBITDAreCredit loss reserve8,672
EBITDAreADJUSTED EBITDAre22,76122,77222,97020,06821,596
EBITDAreADJUSTED EBITDAre ANNUALIZED (4)91,044

Income Statement

Three Months Ended March 31, — (Dollars and shares in thousands, except per share amounts)

Three Months Ended March 31, – 2026 – (Unaudited)Three Months Ended March 31, – 2025 – (Unaudited)
REVENUESRental income31,26929,730
REVENUESOther operating interest255348
REVENUES31,52430,078
EXPENSESProperty operating6,3696,095
EXPENSESGeneral and administrative5,1085,100
EXPENSESDepreciation and amortization10,65710,943

Balance Sheet

FINANCIAL HIGHLIGHTS (Continued)

As of – 1Q 2026 – (Unaudited and dollars in thousands)As of – 4Q 2025 – (Unaudited and dollars in thousands)As of – 3Q 2025 – (Unaudited and dollars in thousands)As of – 2Q 2025 – (Unaudited and dollars in thousands)As of – 1Q 2025 – (Unaudited and dollars in thousands)
Total real estate properties1,238,0801,203,2291,190,1511,158,3121,148,772
Total assets1,010,093990,757987,261966,292985,114
CAPITALIZATIONNet debt559,260532,199530,138500,077496,016
CAPITALIZATIONTotal capitalization1,271,5611,241,9021,229,4421,200,8581,210,874
CAPITALIZATIONNet debt/total capitalization4442.943.141.641
CAPITALIZATIONMarket valuation454,006467,501435,613471,766514,631
CAPITALIZATIONEnterprise value1,010,649996,360962,368966,9801,008,376

Balance Sheet

CONSOLIDATED BALANCE SHEETS (Unaudited; Dollars and shares in thousands, except per share data)

As of – 1Q 2026 – (Unaudited; Dollars and shares in thousands, except per share data)As of – 4Q 2025 – (Unaudited; Dollars and shares in thousands, except per share data)As of – 3Q 2025 – (Unaudited; Dollars and shares in thousands, except per share data)As of – 2Q 2025 – (Unaudited; Dollars and shares in thousands, except per share data)As of – 1Q 2025 – (Unaudited; Dollars and shares in thousands, except per share data)
Real estate propertiesLand and land improvements162,587154,673154,272152,887149,506
Real estate propertiesBuildings, improvements, and lease intangibles1,074,6801,047,7431,035,0701,004,616998,933
Real estate propertiesPersonal property813813809809333
Real estate propertiesTotal real estate properties1,238,0801,203,2291,190,1511,158,3121,148,772
Real estate propertiesLess accumulated depreciation-290,958-280,316-272,481-262,961-253,537
Real estate propertiesTotal real estate properties, net947,122922,913917,670895,351895,235
Real estate propertiesCash and cash equivalents2,6173,3403,3834,8632,271
Real estate propertiesAssets held for sale, net5,2656,2055,4656,755
Real estate propertiesOther assets, net60,35459,23960,00360,61380,853
Real estate propertiesTotal assets1,010,093990,757987,261966,292985,114
LiabilitiesDebt, net559,260532,199530,138500,077496,016
LiabilitiesAccounts payable and accrued liabilities16,43114,92517,20513,94412,058
LiabilitiesOther liabilities, net13,05914,24613,09514,45115,719
LiabilitiesTotal liabilities588,750561,370560,438528,472523,793
Stockholders' EquityCommon stock, $0.01 par value; 450,000 shares authorized286285285284283
Stockholders' EquityAdditional paid-in capital719,819717,450714,890712,498706,776
Stockholders' EquityCumulative net income93,32590,77776,34974,70987,266
Stockholders' EquityAccumulated other comprehensive gain7,3956,6917,5689,12112,402
Stockholders' EquityCumulative dividends-399,482-385,816-372,269-358,792-345,406
Stockholders' EquityTotal stockholders’ equity421,343429,387426,823437,820461,321
Stockholders' EquityTotal liabilities and stockholders' equity1,010,093990,757987,261966,292985,114

Balance Sheet

(Dollars and shares in thousands, except per share amounts)

(Unaudited) – March 31, 2026December 31, 2025
Real estate properties:Land and land improvements162,587154,673
Real estate properties:Buildings, improvements, and lease intangibles1,074,6801,047,743
Real estate properties:Personal property813813
Real estate properties:Total real estate properties1,238,0801,203,229
Real estate properties:Less accumulated depreciation-290,958-280,316
Real estate properties:Total real estate properties, net947,122922,913
Real estate properties:Cash and cash equivalents2,6173,340
Real estate properties:Assets held for sale5,265
Real estate properties:Other assets, net60,35459,239
Real estate properties:Total assets1,010,093990,757
LiabilitiesDebt, net559,260532,199
LiabilitiesAccounts payable and accrued liabilities16,43114,925
LiabilitiesOther liabilities, net13,05914,246
LiabilitiesTotal liabilities588,750561,370
Stockholders' EquityCommon stock, $0.01 par value; 450,000 shares authorized; 28,572 and 28,471 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively286285
Stockholders' EquityAdditional paid-in capital719,819717,450
Stockholders' EquityCumulative net income93,32590,777
Stockholders' EquityAccumulated other comprehensive gain7,3956,691
Stockholders' EquityCumulative dividends-399,482-385,816
Stockholders' EquityTotal stockholders’ equity421,343429,387
Stockholders' EquityTotal liabilities and stockholders' equity1,010,093990,757
Full release

Cautionary Note Regarding Forward-Looking Statements

In addition to the historical information contained within, the matters discussed in this press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identifiable by use of forward-looking terminology such as “believes”, “expects”, “may”, “will,” “should”, “seeks”, “approximately”, “intends”, “plans”, “estimates”, “anticipates” or other similar words or expressions, including the negative thereof. Forward-looking statements are based on certain assumptions and can include future expectations, future plans and strategies, financial and operating projections or other forward-looking information. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. Because forward-looking statements relate to future events, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the control of Community Healthcare Trust Incorporated (the "Company"). Thus, the Company’s actual results and financial condition may differ materially from those indicated in such forward-looking statements. Some factors that might cause such a difference include the following: general volatility of the capital markets and the market price of the Company’s common stock, changes in the Company’s business strategy, availability, terms and deployment of capital, changes in the real estate industry in general, interest rates or the general economy, adverse developments related to the healthcare industry, changes in governmental regulations, the degree and nature of the Company’s competition, the ability to consummate acquisitions under contract, catastrophic or extreme weather and other natural events and the physical effects of climate change, the occurrence of cyber incidents, effects on global and national markets as well as businesses resulting from increased inflation, changes in interest rates, supply chain disruptions, labor conditions, prolonged government shutdown or budgetary reductions or impasses, tariffs and global trade tensions, and/or international conflicts, and the other factors described in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, and the Company’s other filings with the Securities and Exchange Commission from time to time. Readers are therefore cautioned not to place undue reliance on the forward-looking statements contained herein which speak only as of the date hereof. The Company intends these forward-looking statements to speak only as of the time of this press release and undertakes no obligation to update forward-looking statements, whether as a result of new information, future developments, or otherwise, except as may be required by law.²

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Community Healthcare Trust earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.